KS SB 360
deadEnacting the Kansas consumer prescription protection and accountability act and providing for regulation and registration of pharmacy benefits managers.
Kansas · 2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did KS SB 360 pass?
No. KS SB 360 did not pass — it was defeated or died in the legislative process. Latest recorded action (2026-04-10): Died in House Committee
What is KS SB 360 about?
KS SB 360 is a bill in the 2026 Regular Session titled “Enacting the Kansas consumer prescription protection and accountability act and providing for regulation and registration of pharmacy benefits managers.”.
Who sponsors KS SB 360?
Committee on Financial Institutions and Insurance is the primary sponsor of KS SB 360.
- Introduced
- 2026-01-22
- Latest action
- 2026-04-10 — Died in House Committee
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Committee on Financial Institutions and Insuranceprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-04-10
Died in House Committee
failure
2026-04-09
Withdrawn from House Committee on Health and Human Services; Rereferred to House Committee on Health and Human Services
referral-committee
2026-03-17
Withdrawn from House Committee on Insurance; Rereferred to House Committee on Insurance
referral-committee
2026-03-13
Withdrawn from House Committee on Health and Human Services; Referred to House Committee on Health and Human Services
referral-committee
2026-03-05
Withdrawn from House Committee on Insurance; Rereferred to House Committee on Insurance
referral-committee
2026-03-04
Withdrawn from House Committee on Health and Human Services; Referred to House Committee on Health and Human Services
referral-committee
2026-02-25
Received and Introduced
introduction
2026-02-25
Referred to House Committee on Insurance
referral-committee
2026-02-18
Committee of the Whole - Committee Report be adopted
passage
2026-02-18
Committee of the Whole - Motion to Amend - Offered by Sen. Brenda Dietrich
2026-02-18
Committee of the Whole - Amendment by Sen. Brenda Dietrich was adopted
passage
2026-02-18
Committee of the Whole - Motion to Amend - Offered by Sen. Kellie Warren
2026-02-18
Committee of the Whole - Amendment by Sen. Kellie Warren was adopted
passage
2026-02-18
Committee of the Whole - Motion to Amend - Offered by Sen. Jeff Klemp
2026-02-18
Committee of the Whole - Amendment by Sen. Jeff Klemp was withdrawn
2026-02-18
Committee of the Whole - Motion to Amend - Offered by Sen. Beverly Gossage
2026-02-18
Committee of the Whole - Amendment by Sen. Beverly Gossage was rejected
2026-02-18
Committee of the Whole - Motion to Amend - Offered by Sen. Beverly Gossage
2026-02-18
Committee of the Whole - Amendment by Sen. Beverly Gossage was rejected
2026-02-18
Committee of the Whole - Be passed as further amended
passage
2026-02-18
Emergency Final Action - Passed as amended; Yea 32, Nay 8
passage
2026-02-06
Committee Report recommending bill be passed as amended by Senate Committee on Financial Institutions and Insurance
committee-passage-favorable
2026-01-23
Referred to Senate Committee on Financial Institutions and Insurance
referral-committee
2026-01-22
Introduced
introduction
Versions
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T04:56:44.586501Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=KS&identifier=SB 360. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.